Arich Enterprise Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 09, 2022
Share
Arich Enterprise Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 278.75 million compared to TWD 246.97 million a year ago. Revenue was TWD 254.48 million compared to TWD 243.59 million a year ago.
Net income was TWD 12.18 million compared to TWD 11.5 million a year ago. Basic earnings per share from continuing operations was TWD 0.16 compared to TWD 0.15 a year ago. Diluted earnings per share from continuing operations was TWD 0.16 compared to TWD 0.15 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
